Clinical Trials Browser

Phase 4 × Neoplasms × netupitant, palosentron drug combination × Clear all

NCT03831633 2019-02-06

Comparative Effectiveness of AKYNZEO® and Standard of Care (Including EMEND®) for the Prevention of Nausea and Vomiting (CINV) in Cancer Patients

Phase 4 Unknown

Neoplasms